Logo image
Use of iQPR-H2O for bone regeneration and its potential in the improvement of osteoporosis
期刊文章   開放取用(OA)

Use of iQPR-H2O for bone regeneration and its potential in the improvement of osteoporosis

Chiming Lee, Meileng Cheong, Wentien Hsiao, Henyu Liu, Chingyu Tsai, Mingfu Wang, Chihhsiung Wu, Kwanghwa Chang, Gowlin Lam 和 Winping Deng
BMC Musculoskeletal Disorders, 卷.12, 227
2011
PMID: 21981964

摘要

bone mass density mouse fibroblasts osteoporosis Quantum Persistent Reflection senescence-accelerated mice Rheumatology Orthopedics and Sports Medicine
Background: Current treatments for osteoporosis are associated with various side effects and do not prevent the age-related decrease in osteoblast number. The objective of this study was to evaluate the effects of iQPR-H 2 O on osteogenesis. Methods. Mouse fibroblast NIH3T3 and pre-osteoblastic MC3T3-E1 cells were cultured in medium prepared with iQPR-H 2 O or unprocessed mineral water (control cells), and proliferation and differentiation were assessed by MTT and alkaline phosphatase assay, respectively. Mineral deposition by the cells was determined using Alizarin red S staining. A mouse model of osteoporosis, ovariectomized SAMP8 mice, was used to evaluate the effects of iQPR-H 2 O on osteogenesis in vivo. Mice were given either iQPR-H 2 O or unprocessed mineral water (control group) for four months after which bone mass density (BMD) measurements were made using a bone densitometer and hematoxylin and eosin staining of bone samples. Results: NIH3T3 cells grown in medium prepared with iQPR-H 2 O exhibited significantly greater proliferation. NIH3T3 and MC3T3-E1 cells demonstrated a significant increase in alkaline phosphatase levels in the iQPR-H 2 O group. MC3T3-E1 cells showed mineralization at day 28. mRNA expression levels of both osteopontin and runt-related transcription factor 2 in MC3T3-E1 cells were higher in the iQPR-H 2 O group compared with the control group. After four months, significantly greater bone regeneration was evident in ovariectomized SAMP8 mice administered iQPR-H 2 O as compared with control group. Conclusions: iQPR-H 2 O may reduce the symptoms of osteoporosis by improving osteogenesis. © 2011 Lee et al; licensee BioMed Central Ltd.

檔案與連結 (1)

url
https://doi.org/10.1186/1471-2474-12-227檢視
已出版(紀錄版本) 開放

相關連結

指標

1 檢視次數

詳細資料

Logo image